Edgewise Therapeutics, Inc.

The momentum for this stock is not very good. Edgewise Therapeutics, Inc. is not very popular among insiders. Edgewise Therapeutics, Inc. is a mediocre stock to choose.

News

Head-To-Head Contrast: Edgewise Therapeutics (NASDAQ:EWTX) & Regeneron Pharmaceuticals (NASDAQ:REGN)

Zolmax Edgewise Therapeutics (NASDAQ:EWTX - Get Free Report) and Regeneron Pharmaceuticals (NASDAQ:REGN - Get Free Report) are both medical companies, but which is the superior stock? We will contrast the...\n more…

Reviewing Edgewise Therapeutics (NASDAQ:EWTX) & Regeneron Pharmaceuticals (NASDAQ:REGN)

Ticker Report Edgewise Therapeutics (NASDAQ:EWTX - Get Free Report) and Regeneron Pharmaceuticals (NASDAQ:REGN - Get Free Report) are both medical companies, but which is the better investment? We will compare the...\n more…

Optimistic Buy Rating for Edgewise Therapeutics Amid Promising EDG-7500 Developments

TipRanks Financial Blog Leerink Partners analyst Joseph Schwartz has maintained their bullish stance on EWTX stock, giving a Buy rating on August 16. Joseph Schwartz has g...\n more…

Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Short Interest Update

Zolmax Edgewise Therapeutics, Inc. (NASDAQ:EWTX - Get Free Report) was the target of a significant decrease in short interest in July. As of July 31st, there was short interest totalling 8,080,000 shares...\n more…

Edgewise Therapeutics (NASDAQ:EWTX) Earns "Outperform" Rating from Wedbush

Ticker Report Wedbush reissued their outperform rating on shares of Edgewise Therapeutics (NASDAQ:EWTX - Free Report) in a research note published on Friday, Benzinga reports. They currently have a $31.00 price...\n more…

Edgewise Therapeutics (NASDAQ:EWTX) Shares Down 3.6%

Zolmax Edgewise Therapeutics, Inc. (NASDAQ:EWTX - Get Free Report) shares traded down 3.6% during trading on Friday . The stock traded as low as $18.20 and last traded at $18.20. 218,817 shares changed...\n more…